💊SUMITOMO DAINIPPON PHARMA CO., LTD. Filed Additional Patent Infringement Lawsuit Regarding LATUDA in the United States
Sumitomo Dainippon Pharma Co., Ltd. (“Sumitomo Dainippon Pharma” or “we”) filed a patent
infringement lawsuit jointly with its U.S. subsidiary, Sunovion Pharmaceuticals Inc. (“Sunovion”) on
February 23, 2018 (U.S. Eastern Time) in the U.S. District Court for the District of New Jersey against
fifteen companies* and related companies regarding their submissions of Abbreviated New Drug
Applications for generic copies of LATUDA® (lurasidone HCl tablets). The lawsuit alleges infringement
of Sumitomo Dainippon Pharma’s U.S. Patent No. 9,815,827 (“the ’827 Patent”). The lawsuit is similar
to the lawsuits announced in Sumitomo Dainippon Pharma’s press release issued on February 14,
2018.
SUMITOMO DAINIPPON PHARMA Co